Autoantibody-positivity Before Treatment Is Associated with Immune-related Adverse Events in Melanoma Patients Treated with anti-PD-1

被引：0
|
作者：
van Wesemael, Tineke [1 ]
Borgers, Jessica [2 ]
Gelderman, Kyra [3 ]
Verdegaal, Els [4 ]
Korse, C. M. [5 ]
Welters, M. J. P. [6 ]
Kapiteijn, Ellen [7 ]
van Houdt, W. J. [2 ]
van der Burg, Sjoerd [6 ]
Toes, Rene [1 ]
Thienen, J. V. [2 ]
Haanen, John [2 ]
van der Woude, Diane [1 ]
机构：
[1] Leiden Univ Med Ctr, Leiden, Netherlands
[2] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[3] Sanquin Diagnost Serv, Amsterdam, Netherlands
[4] Leiden Univ Med Ctr, Oncode Inst, Dept Med Oncol, Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Lab Med, Antoni Van Leeuwenhoek, Amsterdam, Netherlands
[6] Leiden Univ Med Ctr, Oncode Inst, Dept Med Oncol, Leiden, Netherlands
[7] Leiden Univ Med Ctr, Dept Med Oncol, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2510
引用
收藏
页码：4977 / 4979
页数：3
相关论文
共 50 条
  • [31] Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events
    Swami, Umang
    Monga, Varun
    Bossler, Aaron D.
    Zakharia, Yousef
    Milhem, Mohammed
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [32] Serum multiplex analysis of checkpoint proteins in association with immune-related adverse events in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Bruno, Sabrina
    Layding, Caroline Jane
    Wang, Hong
    Sander, Cindy
    Storkus, Walter J.
    Karapetyan, Lilit
    Kirkwood, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Immunological features of immune-related adverse events during anti-PD-1/PD-L1 immune checkpoint inhibition
    Goswami, Meghali
    Gui, Gege
    Lindblad, Katherine
    Del Rivero, Jaydira
    Marte, Jennifer
    Dagur, Pradeep
    Destefano, Christin
    Thompson, Julie
    Popescu, Bogdan
    Dillon, Laura
    Johnson, Cheryl
    Soldin, Steven
    Lai, Catherine
    Gulley, James
    Hourigan, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [34] Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
    Gay, Cynthia L.
    Bosch, Ronald J.
    McKahnn, Ashley
    Moseley, Kendall F.
    Wimbish, Chanelle L.
    Hendrickx, Steven M.
    Messer, Michael
    Furlong, Maureen
    Campbell, Danielle M.
    Jennings, Cheryl
    Benson, Constance
    Overton, Edgar T.
    Macatangay, Bernard J. C.
    Kuritzkes, Daniel R.
    Miller, Elizabeth
    Tressler, Randall
    Eron, Joseph J.
    Hardy, William David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 87 (05) : E234 - E236
  • [35] Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)
    Dimitriou, F.
    Cheng, P.
    Saltari, A.
    Staeger, R.
    Tastanova, A.
    Levesque, M.
    Long, G.
    Becher, B.
    Dummer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S275 - S275
  • [36] Association between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1
    Kfoury, M.
    Voisin, A-L.
    Najean, M.
    Champiat, S.
    Laghouati, S.
    Michot, J-M.
    Robert, C.
    Mateus, C.
    Albiges, L.
    Besse, B.
    Massard, C.
    Texier, M.
    Lambotte, O.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Immune-related adverse events in a nationwide cohort of melanoma patients treated with adjuvant anti-PD1: Seasonal variation and association with outcome
    Ellebaek, E.
    Jurlander, R. S.
    Guldbrandt, L. M.
    Holmstroem, R. B.
    Donia, M.
    Haslund, C. A.
    Schmidt, H.
    Bastholt, L.
    Ruhlmann, C. H.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2023, 34 : S690 - S690
  • [38] Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
    Suo, Aleksi
    Chan, Yin
    Beaulieu, Carissa
    Kong, Shiying
    Cheung, Winson Y.
    Monzon, Jose G.
    Smylie, Michael
    Walker, John
    Morris, Don
    Cheng, Tina
    ONCOLOGIST, 2020, 25 (05): : 438 - 446
  • [39] Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab
    Mian, Idrees
    Yang, Ming
    Zhao, Hui
    Shah, Mohsin
    Diab, Adi
    Shannon, Vickie
    Patel, Anisha
    Amaria, Rodabe Navroze
    Giordano, Sharon Hermes
    Suarez-Almazor, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
    Gault, A.
    Anderson, A. E.
    Plummer, R.
    Stewart, C.
    Pratt, A. G.
    Rajan, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) : 263 - 271
12345